Literature DB >> 18796628

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.

Lindsay M Morton1, Sophia S Wang, Wendy Cozen, Martha S Linet, Nilanjan Chatterjee, Scott Davis, Richard K Severson, Joanne S Colt, Mohammad A Vasef, Nathaniel Rothman, Aaron Blair, Leslie Bernstein, Amanda J Cross, Anneclaire J De Roos, Eric A Engels, David W Hein, Deirdre A Hill, Linda E Kelemen, Unhee Lim, Charles F Lynch, Maryjean Schenk, Sholom Wacholder, Mary H Ward, Shelia Hoar Zahm, Stephen J Chanock, James R Cerhan, Patricia Hartge.   

Abstract

Understanding patterns of etiologic commonality and heterogeneity for non-Hodgkin lymphomas may illuminate lymphomagenesis. We present the first systematic comparison of risks by lymphoma subtype for a broad range of putative risk factors in a population-based case-control study, including diffuse large B-cell (DLBCL; N = 416), follicular (N = 318), and marginal zone lymphomas (N = 106), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL; N = 133). We required at least 2 of 3 analyses to support differences in risk: (1) polytomous logistic regression, (2) homogeneity tests, or (3) dichotomous logistic regression, analyzing all 7 possible pairwise comparisons among the subtypes, corresponding to various groupings by clinical behavior, genetic features, and differentiation. Late birth order and high body mass index (>/= 35) kg/m(2)) increased risk for DLBCL alone. Autoimmune conditions increased risk for marginal zone lymphoma alone. The tumor necrosis factor G-308A polymorphism (rs1800629) increased risks for both DLBCL and marginal zone lymphoma. Exposure to certain dietary heterocyclic amines from meat consumption increased risk for CLL/SLL alone. We observed no significant risk factors for follicular lymphoma alone. These data clearly support both etiologic commonality and heterogeneity for lymphoma subtypes, suggesting that immune dysfunction is of greater etiologic importance for DLBCL and marginal zone lymphoma than for CLL/SLL and follicular lymphoma.

Entities:  

Mesh:

Year:  2008        PMID: 18796628      PMCID: PMC2597610          DOI: 10.1182/blood-2008-01-133587

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  63 in total

1.  Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study.

Authors:  Amanda J Cross; Mary H Ward; Maryjean Schenk; Martin Kulldorff; Wendy Cozen; Scott Davis; Joanne S Colt; Patricia Hartge; James R Cerhan; Rashmi Sinha
Journal:  Carcinogenesis       Date:  2005-08-19       Impact factor: 4.944

2.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.

Authors:  Eric A Engels; James R Cerhan; Martha S Linet; Wendy Cozen; Joanne S Colt; Scott Davis; Gloria Gridley; Richard K Severson; Patricia Hartge
Journal:  Am J Epidemiol       Date:  2005-10-26       Impact factor: 4.897

4.  Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis.

Authors:  Lindsay M Morton; Tongzhang Zheng; Theodore R Holford; Elizabeth A Holly; Brian C H Chiu; Adele Seniori Costantini; Emanuele Stagnaro; Eleanor V Willett; Luigino Dal Maso; Diego Serraino; Ellen T Chang; Wendy Cozen; Scott Davis; Richard K Severson; Leslie Bernstein; Susan T Mayne; Fred R Dee; James R Cerhan; Patricia Hartge
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

5.  Birth order, atopy, and risk of non-Hodgkin lymphoma.

Authors:  Andrew Edwin Grulich; Claire Melissa Vajdic; John Martin Kaldor; Ann Maree Hughes; Anne Kricker; Lin Fritschi; Jennifer Jane Turner; Sam Milliken; Geza Benke; Bruce Konrad Armstrong
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

Review 6.  Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph).

Authors:  Lindsay M Morton; Patricia Hartge; Theodore R Holford; Elizabeth A Holly; Brian C H Chiu; Paolo Vineis; Emanuele Stagnaro; Eleanor V Willett; Silvia Franceschi; Carlo La Vecchia; Ann Maree Hughes; Wendy Cozen; Scott Davis; Richard K Severson; Leslie Bernstein; Susan T Mayne; Fred R Dee; James R Cerhan; Tongzhang Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

7.  Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.

Authors:  F D Groves; M S Linet; L B Travis; S S Devesa
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

8.  Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

Authors:  Nathaniel Rothman; Christine F Skibola; Sophia S Wang; Gareth Morgan; Qing Lan; Martyn T Smith; John J Spinelli; Eleanor Willett; Silvia De Sanjose; Pierluigi Cocco; Sonja I Berndt; Paul Brennan; Angela Brooks-Wilson; Sholom Wacholder; Nikolaus Becker; Patricia Hartge; Tongzhang Zheng; Eve Roman; Elizabeth A Holly; Paolo Boffetta; Bruce Armstrong; Wendy Cozen; Martha Linet; F Xavier Bosch; Maria Grazia Ennas; Theodore R Holford; Richard P Gallagher; Sara Rollinson; Paige M Bracci; James R Cerhan; Denise Whitby; Patrick S Moore; Brian Leaderer; Agnes Lai; Charlotte Spink; Scott Davis; Ramon Bosch; Aldo Scarpa; Yawei Zhang; Richard K Severson; Meredith Yeager; Stephen Chanock; Alexandra Nieters
Journal:  Lancet Oncol       Date:  2006-01       Impact factor: 41.316

9.  Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998-2000.

Authors:  U Lim; M Schenk; L E Kelemen; S Davis; W Cozen; P Hartge; M H Ward; R Stolzenberg-Solomon
Journal:  Am J Epidemiol       Date:  2005-10-12       Impact factor: 4.897

10.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes.

Authors:  Bernice R Packer; Meredith Yeager; Laura Burdett; Robert Welch; Michael Beerman; Liqun Qi; Hugues Sicotte; Brian Staats; Mekhala Acharya; Andrew Crenshaw; Andrew Eckert; Vinita Puri; Daniela S Gerhard; Stephen J Chanock
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  76 in total

1.  Spatial-temporal analysis of non-Hodgkin lymphoma risk using multiple residential locations.

Authors:  David C Wheeler; Lance A Waller; Wendy Cozen; Mary H Ward
Journal:  Spat Spatiotemporal Epidemiol       Date:  2012-04-21

2.  A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults.

Authors:  Jennifer L Kelly; Jonathan W Friedberg; Laura M Calvi; Edwin van Wijngaarden; Susan G Fisher
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

3.  Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.

Authors:  Jill Koshiol; Tram Kim Lam; Gloria Gridley; David Check; Linda Morris Brown; Ola Landgren
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

4.  Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.

Authors:  Hui-Lee Wong; Elizabeth C Breen; Ruth M Pfeiffer; Brahim Aissani; Jeremy J Martinson; Joseph B Margolick; Richard A Kaslow; Lisa P Jacobson; Richard F Ambinder; Stephen Chanock; Otoniel Martínez-Maza; Charles S Rabkin
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

5.  A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.

Authors:  Kimberly A Bertrand; Brenda M Birmann; Ellen T Chang; Donna Spiegelman; Jon C Aster; Shumin M Zhang; Francine Laden
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

6.  A prospective analysis of blood donation history and risk of non-Hodgkin lymphoma.

Authors:  Kazusa Ishii; Brenda M Birmann; Xuehong Zhang; Edward Giovannucci; Kimberly A Bertrand
Journal:  Leuk Lymphoma       Date:  2015-10-16

7.  Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.

Authors:  Jun Wang; Thomas M Mack; Ann S Hamilton; Amie E Hwang; Bharat N Nathwani; Kamil Masood; Laura H Buchanan; Leslie Bernstein; Dennis M Deapen; Otoniel Martínez-Maza; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2015-08-12       Impact factor: 4.897

8.  Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men.

Authors:  Kimberly A Bertrand; Donna Spiegelman; Jon C Aster; Larisa M Altshul; Susan A Korrick; Scott J Rodig; Shumin M Zhang; Tobias Kurth; Francine Laden
Journal:  Epidemiology       Date:  2010-03       Impact factor: 4.822

9.  Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Authors:  Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-26       Impact factor: 4.254

10.  A Systematic Review of Carcinogenic Outcomes and Potential Mechanisms from Exposure to 2,4-D and MCPA in the Environment.

Authors:  Katherine von Stackelberg
Journal:  J Toxicol       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.